In case you missed it, here is this week’s big news roundup for cannabis:
- High Tide to Acquire Remaining 49.9 Percent of KushBar Joint Venture with 4 Retail Cannabis Locations in Alberta
- WKND! Branded Products Sales and Distribution in Full Operation in Oklahoma
- TILT Holdings’ Blackbird Launches Innovative New All-in-One Cannabis Retail Platform for Sales, Home Delivery and Customer Management
- Next Green Wave’s Brand House SDC and The Fader Unveil Exclusive Cannabis Partnership
- World-Class Extractions Announces Agreement to Deploy Extraction and Processing Centre in California for Hemp Oil
- Heritage Announces Research Partnership with Brock University
- Yield Growth Announces Completion of Production of 5 SKU’s of Wright & Well CBD and THC Products in Oregon
- CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems
- Valens Expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets
- DNA Genetics Enters CBD Market Through Licensing Deal with 1933 Industries
- TransCanna to Maximize Value Proposition with Expansion of Sales, Fulfillment and Distribution Strategy
To see our previous Cannabis Investing News Roundups, please click here.
Cannabis Big News Roundup: RYAH Inhaler Passes Major Safety Test Milestone; Heritage Launches EndoDNA Canada; Harvest One Signs Supply Agreement with the AGLC
In case you missed it, here is this week’s big news roundup for cannabis:
- CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia
- Yield Growth Subsidiary Yield Botanicals signs LOI to Acquire Canniva Capital and enter European CBD Market
- TILT Holdings’ Jupiter Research Together with Convectium Launching Proprietary Pre-Rack Solutions
- Mota Ventures Completes Acquisition of Colombian Licensed Producer and Begins Trading on December 4, 2019
- Sire Bioscience Inc. Begins Construction on 50-Acre Leamington, ON Property
- Harvest One Signs Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission
- Heritage Announces Launch of EndoDNA Canada
- RYAH Inhaler Passes Major Safety Test Milestone
To see our previous Cannabis Investing News Roundups, please click here.
In case you missed it, here is this week’s big news roundup for cannabis:
- Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
- Yield Growth Closes Agreement to License 126 Product Formulas to Subsidiary Flourish Mushroom Labs
- High Tide Opens 26th Canna Cabana and 3rd KushBar Bringing its Total to 29 Branded Retail Cannabis Stores across Canada
- Biome Grow’s Highland Grow Products Approved for Sale in PEI
- Asterion Receives Development Approval Permit for its Medicinal Cannabis Propagation and Processing Facility
- PRIMO Nutraceuticals Inc. Harvests 13,000 lbs of Dried Bio-mass from Oregon Hemp Farm
- TransCanna and Lyfted Farms Sign Definitive Purchase Agreement
- Flower One Announces Brand Partnership with Preeminent California Cannabis and Lifestyle Brand, Cookies
To see our previous Cannabis Investing Big News Roundups, please click here.
Primo Nutraceuticals: Providing Turnkey Infrastructure Solutions to Cannabis Producers
Primo Nutraceuticals Inc. (CSE:PRMO,FWB:8BV) has launched its campaign on the Investing News Network’s cannabis channel.
Primo Nutraceuticals provides infrastructure and seed-to-sale services to licensed tenant cannabis growers in Washington state. The company owns a four-acre property in the Okanogan Valley in Washington state as well as senior water rights for the land. The property hosts a 10,000-square-foot greenhouse, which has been leased to a tenant grower. Primo Nutraceuticals is currently building out two additional 10,000-square-foot greenhouses on the property and intends to expand its land package by at least six acres.
1933 Industries CEO: Infrastructure Upgrades Expanding Cultivation Capacity by 500 Percent
1933 Industries Inc. (CSE:TGIF,OTCQX:TGIFF,FWB:IQF) CEO Chris Rebentisch recently joined the Stock Day podcast to discuss the company’s expansion plans, including a new 67,000-square-foot cannabis cultivation facility. Rebentisch also provided an overview of the company’s recent progress, including a partnership with skateboarding legend Tony Hawk.
The company’s 67,000-square-foot, state-of-the-art indoor cultivation facility in Nevada is expected to increase 1933 Industries’ cultivation capacity by 500 percent. Rebentisch expects the first harvest from the facility to begin in December. As for the old facility, 1933 Industries intends to retrofit it to a 10,000-square-foot extraction facility, to ensure that the company can meet its current product quotas. According to Rebentisch, the company’s existing extraction facility is running for 16 hours per day to keep up with the current demand.
Harvest One’s Subsidiary Satipharm Talks About Gelpell® Technology
Harvest One Cannabis Inc. (TSXV:HVT, OTCQX:HRVOF) subsidiary Satipharm AG spoke about the proprietary Gelpell® technology during the Dublin Marathon Expo in Dublin, Ireland. Satipharm AG is a health and well-being company that specializes in the development and manufacturing of cannabinoid-based products.
Gelpell® technology is designed to help address the bioavailability and consistency issues associated with the delivery of orally-ingested cannabis-based products. Satipharm has completed clinical trials on the Gelpell® capsules with PhytoTech Therapeutics Limited (PTL). Satipharm representative Matthew Gavin talked about CBD capsules and Gelpell® technology, and said, “it makes it 360 percent more effective than oils, so our phase one and phase two clinical trials showed us data that we can place cannabinoids into micro-gelatin spheres.”